Judge Denies AstraZeneca's Seroquel Challenge But Blasts FDA
A federal judge on Wednesday rejected AstraZeneca PLC's attempt to block generic versions of its antipsychotic drug Seroquel from going to market, but also criticized the U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article